Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 29 filings.
20 Aug 2026 1 filing
CSR corrigendum
CSR spend FY26 corrected from ₹41.50 Crores to ₹41.50 Lakhs.
Statutory CSR Obligation corrected from ₹51.61 Crores to ₹51.61 Lakhs.
Correction pertains to non-statutory CSR figures; no financial statements impact.
17 Aug 2026 1 filing
Business overview
Animal health specialist focused on veterinary APIs; operates three manufacturing facilities.
Phase II expansion underway to support next growth leg.
Key operational highlights
Q1FY27 volumes robust across segments and geographies.
Forex MTM reversal boosted profitability in Q1FY27.
Phase II capex on track; commissioning expected this quarter.
Tarapur greenfield expansion capex ₹210 crore; capacity to meet demand.
Financial performance
Q1FY27 revenue from operations ₹139.16 crore.
Total income ₹146.59 crore in Q1FY27.
EBITDA ₹23.29 crore; margin 16.73%.
PAT ₹18.40 crore in Q1FY27.
YoY revenue growth 33.57%.
Capital structure & liquidity
Long-term borrowings ₹56.40 crore; short-term ₹52.02 crore (FY26).
Cash and bank balances ₹5.11 crore (FY26).
CFO FY26 ₹43.32 crore.
Strategic priorities & outlook
Tarapur greenfield capex ₹210 crore funded via debt and accruals.
Phase II on track; commercial production in H2 FY27.
Longer-term growth driven by demand and operating leverage.
Risks & mitigation
Margin moderation as price realisations normalise.
Forex movements remain volatile; management emphasises earnings resilience.
Governance & leadership
Management commentary by MD Rahul Nachane; no governance changes disclosed.
12 Aug 2026 2 filings
Fines by stock exchanges and board response
NSE and BSE issued fines for delay in board meeting intimation under Reg 29(2)/29(3) LODR; fines paid.
Fines: Rs 11,800 per exchange; total payable Rs 23,600 incl GST.
Notices dated June 15, 2026; board comments presented at Aug 12, 2026 meeting.
Delay deemed inadvertent; due to procedural lapse; board to bolster internal compliance monitoring.
Management instructed to ensure strict adherence to timelines; fines remittance details to NEAPS.
Waiver process outlined by exchanges; payment within 15 days; potential promoter share freezing if non-compliant.
Financial results approved
Unaudited standalone and consolidated results for quarter ended 30 June 2026 approved.
Limited Review Report by statutory auditors accompanies the results.
Results prepared under Ind AS and SEBI LODR Regulation 33.
Consolidated results include 100% subsidiary Macrotech Polychem Private Limited.
Audit and governance disclosures
Auditors' review concluded no material misstatement.
Board approval date: 12 August 2026 following Audit Committee review.
31 Jul 2026 2 filings
Overview
Standalone BRSR for FY2025-26; NGL Fine-Chem is a pharmaceutical manufacturer.
Exports cover 54 countries; exports account for over 75% of turnover.
ESG framework centers on Environmental, Resilience, and Efficiency pillars.
Reporting boundary is standalone; BRSR forms part of the Integrated Annual Report.
Key ESG Risks & Opportunities
Regulatory/compliance ESG risk could impact operations and investor confidence.
Occupational health and safety risk; mitigated through ISO 45001-based EHS management.
Climate change exposes operations; strategy includes risk mitigation and energy efficiency.
Waste, water, and energy management are material ESG issues.
EPR applies to plastic packaging; plan aligned with MPCB requirements.
Sustainable sourcing includes 69% inputs sourced sustainably.
RPT-related transactions show concentration with top dealers, increasing governance focus.
Governance & Policy Highlights
ESG oversight rests with the Board, emphasizing risk management and transparency.
Code of Conduct covers anti-bribery; Whistleblower policy published on the website.
No standalone anti-corruption policy; compliance integrated under SEBI LODR.
No penalties or fines in FY2026.
OH&S aligned to ISO 45001; one site ISO 14001 certified.
External environmental assurances by MPCB and Green Envirosafe Engineers.
CSR metrics disclosed: CSR turnover and net worth.
Social Responsibility & Workforce
Total employees: 463; permanent 459 and workers 39.
Male permanent employees: 424; female 35.
Board gender representation: 33.33% female.
Wellbeing spend: 0.30% of revenue.
Retirement benefits: PF/Gratuity/ESI/Bonus coverage 100% where applicable.
LTIFR: workers 1.33; employee LTIFR not reported.
Training coverage: board/KMP 100%; employees 87%; workers 98%.
Grievance mechanisms: whistleblower accessible to all employees and workers.
Parental leave return-to-work: 2 returns; retention 100%.
Union membership: 0% for permanent employees and workers.
Human rights training coverage: 0%.
Environmental Performance
Total energy: renewables 0; non-renewables 86,979.78 GJ.
Energy intensity per turnover: 8e-9.
Water withdrawal: 75,001 kL; discharge: 9,266.4 kL.
ZLD with ETP; treated water reused or discharged to CETP.
GHG emissions intensity per turnover is very low.
Waste generated: 881.272 tonnes; plastic 3.575 t; e-waste 1.302 t.
Recycling: 480.539 t; ETP sludge: 326.618 t; incineration 0.32 t; landfilling 157.1 t.
ISO 45001 across all sites; ISO 14001 at one site; API expansion EIA approved.
Stakeholder Engagement & Complaints
Stakeholders: investors, government/regulators, employees, customers, value chain partners.
Engagement channels: website, email, meetings; frequency: annual/quarterly/event-based.
No unresolved complaints in FY2026; unified redressal mechanism in place.
Community engagement includes village meetings, water regeneration projects and tree plantation.
Whistleblower/vigil mechanism accessible; policy uploaded on company site.
Other Notable Metrics
Sustainable sourcing: 69% inputs sourced sustainably.
Exports represent about 75% of turnover.
RPT metrics: purchases from related parties 85%; sales 0.5%.
Loans to related parties 12%; investments in related parties 8.68%.
Top 10 dealers account for 53.26% of sales; total dealers 122.
R&D intensity: 2.9%; capex intensity: 0.01%; capex 6.35 crore.
CSR turnover: 48,219.04 Lakhs; net worth: 31,993.67 Lakhs.
Data privacy policy posted; no data breaches in period.
All plants compliant with environmental laws; API expansion EIA with independent agency.
AGM Details
AGM scheduled for August 25, 2026 at 11:00 IST via VC/OAVM.
Record date for voting/dividend entitlement: August 18, 2026.
Deemed venue: Registered office of the company.
Resolutions Put to Vote
Ordinary: Adopt audited standalone and consolidated financial statements and reports.
Ordinary: Declare final dividend on equity shares.
Ordinary: Appoint Rajesh Lawande, retiring director, for re-appointment.
Special: Re-appoint Rajesh Lawande as Whole-Time Director for five years with remuneration up to ₹4 crore.
Special: Re-appoint Sarala Menon as Independent Director for a second term.
Ordinary: Ratify remuneration payable to Cost Auditor.
Dividend
Proposed final dividend of ₹1.75 per share (aggregate ~₹108 lakh).
Director Changes
Re-appointments: Rajesh Lawande as director; Sarala Menon as Independent Director.
Auditors & Remuneration
Statutory auditors to continue for the next term.
Secretarial auditors to continue for their term.
Internal auditors appointed for the year.
Cost Auditor remuneration approved (₹1,75,000 plus GST).
Related Party Transactions
No material related party transactions requiring shareholder approval.
Other Material Approvals
No Employee Stock Option Plan (ESOP) or stock options in force.
Voting Results
Voting results for resolutions not disclosed in the filing.
13 Jul 2026 1 filing
Dematerialisation processing and listing
Dematerialisation requests for quarter ended June 2026 were processed and confirmed as accepted/rejected to the depositories.
Securities dematerialised have been listed on the stock exchanges where the original securities are listed.
Security certificates received for dematerialisation were mutilated and cancelled after verification, with depositories' name substituted within prescribed timelines.